One of Türkiyeās long-established pharmaceutical companies, Drogsan Pharmaceuticals, has announced a significant leadership transition. Dr. Sabri Ćncel has been appointed as the companyās new Chief Executive Officer, effective March 9, 2026. Former CEO Dr. Ersan Küçük, who led the company for 18 years, will continue contributing as a strategic advisor.
Read More